CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Nutrição from Fundação Universidade Regional de Blumenau (2009), master's at Science and Technology of the Food from Universidade Federal do Pará (2013) and doctorate at Science and Technology of the Food from Universidade de São Paulo (2017). Has experience in Nutrition (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Lowering LDL cholesterol (LDL-C) is the primary clinical approach to prevent cardiovascular events and is often achieved with statin therapy. However, even patients treated with statins have a considerable residual burden of cardiovascular risk, highlighting the need to address risk factors beyond LDL-C, such as inflammation and oxidative stress. Increasing attention has also focused on H…
Atherosclerosis, one major cause of morbidity and mortality worldwide, is a complex and multifactorial disease triggered especially due to high level of plasma lipids and that involves three mainly conditions: chronic inflammation, dyslipidemia and oxidative stress. Taking into account the high costs of disease management, eminent suboptimal response and low compliance to drug therapies, …
In recent years, immunotherapy has gained great attention. The principle of empowering a patient's immune system to perform its natural role - to fight disease - has yet to be applied to reversing atherosclerosis and its clinical manifestations. Plaque regression as a result of LDL cholesterol lowering is very limited and the residual risk of cardiovascular events after treatment with sta…
Atherosclerosis is a complex and multifactorial disease that consists in a chronicinflammation of the artery wall. Lowering LDL cholesterol (LDL-C) is the primary clinicalapproach to prevent cardiovascular events, which is often achieved by statin treatment.However, even patients treated with statins have a considerable residual burden ofcardiovascular risk. Increasing attention has focus…
| 2 / 2 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 4 / 4 | All Scholarships |
| Associated processes | |